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Background: There is growing interest in the development of cell culture assays that enable the rigidity of the
extracellular matrix to be increased. A promising approach is based on three-dimensional collagen type I matrices
that are stiffened by cross-linking through non-enzymatic glycation with reducing sugars.
Methods: The present study evaluated the biomechanical changes in the non-enzymatically glycated type I collagen
matrices, including collagen organization, the advanced glycation end products formation and stiffness achievement.
Gels were glycated with ribose at different concentrations (0, 5, 15, 30 and 240 mM). The viability and the phenotypic
changes of primary human lung fibroblasts cultured within the non-enzymatically glycated gels were also evaluated
along three consecutive weeks. Statistical tests used for data analyze were Mann–Whitney U, Kruskal Wallis, Student’s
t-test, two-way ANOVA, multivariate ANOVA, linear regression test and mixed linear model.
Results: Our findings indicated that the process of collagen glycation increases the stiffness of the matrices and
generates advanced glycation end products in a ribose concentration-dependent manner. Furthermore, we identified
optimal ribose concentrations and media conditions for cell viability and growth within the glycated matrices. The
microenvironment of this collagen based three-dimensional culture induces α-smooth muscle actin and tenascin-C
fibroblast protein expression. Finally, a progressive contractile phenotype cell differentiation was associated with the
contraction of these gels.
Conclusions: The use of non-enzymatic glycation with a low ribose concentration may provide a suitable model with
a mechanic and oxidative modified environment with cells embedded in it, which allowed cell proliferation and
induced fibroblast phenotypic changes. Such culture model could be appropriate for investigations of the behavior
and phenotypic changes in cells that occur during lung fibrosis as well as for testing different antifibrotic therapies
in vitro.
Keywords: Three-dimensional matrices, Collagen, Fibroblasts, Alpha-smooth muscle actin, Non-enzymatic glycation,
Advanced glycation end products (AGEs), Viability, Stiffness, Contractility, Lung fibrosis* Correspondence: vvicens@hotmail.com
†Equal contributors
1Department of Pneumology, Unit of Interstitial Lung Diseases, University
Hospital of Bellvitge, Barcelona, Spain
2Pneumology Research Group, IDIBELL, University of Barcelona, Barcelona,
Spain
Full list of author information is available at the end of the article
© 2015 Vicens-Zygmunt et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Vicens-Zygmunt et al. Respiratory Research  (2015) 16:82 Page 2 of 15Background
Pulmonary extracellular matrix (ECM) is a complex
mesh of proteins, proteoglycans and glycosaminoglycans,
which contains the cells and participates in tissue’s
homeostasis and repair. Active lung fibroblasts, myofi-
broblasts and other cell types, are normally surrounded
by this fibrous three-dimensional (3D) extracellular
matrix and are mainly responsible for the synthesis, se-
cretion and degradation of the ECM components. More-
over, these cells are responsible for the correct turnover
of ECM proteins, preserving the lung architecture and
function [1]. However, most in vitro studies of fibro-
blasts behavior have been performed using conventional
two-dimensional (2D) cultures, which lack the structural
three-dimensionality provided by the ECM in the ori-
ginal tissue. This limitation is important because it can
cause the loss or change of important tissue-specific cell
functions due to the lack of essential ECM signals [2, 3].
A suitable alternative to overcome this limitation is 3D
cultures, in which cells are embedded within ECM gels.
Studies using 3D cultures have shown that the ECM in-
fluences cell behavior through mechanical interactions
and biochemical signals [3–6]. Moreover, these studies
have clearly shown that cell functions and phenotypes
depend on the structure of the microenvironment, such
as the ECM [2–4] and have revealed the profound im-
pact of extracellular forces on the behavior of fibroblasts
and other cell types [3, 7, 8].
On the other hand, fibrotic lung diseases, such as idio-
pathic pulmonary fibrosis (IPF), are characterized by an
excessive ECM deposition and the expansion of the
fibroblast/myofibroblast population leading to an in-
creased parenchyma stiffness and retraction, with final
lung destruction and patient death [9–12]. In this con-
text, the increased matrix stiffening observed in the lung
fibrotic process may be a critical fibrogenesis driving fac-
tor [13, 14]. Unfortunately, suitable 3D culture assays for
the study of fibrotic lung diseases and other aging disor-
ders, primarily mimicking matrix stiffness are scanty.
Therefore, there is growing interest in developing 3D
culture assays that enable increasing the rigidity of the
ECM mimicking the situation observed during fibrotic
processes in vivo. In some 3D culture assays based on
collagen gels, the rigidity of the ECM is modified by
changing the ECM concentration [15]. Alternatively,
ECM stiffness can be changed by increasing the cross-
linking through non-enzymatic glycation with reducing
sugars, which cause the accumulation of the final products
of glycation, i.e., the advanced glycation end products
(AGEs) [3, 5, 16–24]. Interestingly, an excess of AGEs in
aged human tissues has been observed to stiffen tissues in
different degenerative diseases [25] and may accelerate pro-
tein oxidation, altering their structure and threatening their
function [23, 24]. Therefore, various physical characteristicsof the fibrotic lung tissue, such as reduced elastic recoil [2],
decreased matrix degradation [21, 22, 26, 27], oxidative
ECM protein damage [28], may be related to the accumula-
tion of AGEs, contributing to the acceleration of the fi-
brotic process. However, the effects of non-enzymatic
glycation on collagen gels and the resulting behavior of lung
fibroblasts remain largely unknown.
Thus, the aims of this study were: 1) to develop an ex-
perimental culture model system that recreate the bio-
mechanical and three-dimensional conditions of fibrotic
lungs, and 2) to examine the cellular viability and bio-
mechanical changes in the ECM, including AGE forma-
tion and stiffening, in these non-enzymatically glycated
collagen gels. This model may facilitate the experimental
study of the complex cell-extracellular pro-fibrotic inter-
actions, such as those occurring in fibrotic lung diseases,
as IPF.
Methods
Development of non-cellular post-glycated
three-dimensional matrix
The 3D collagen matrices were produced using native
type I collagen from bovine dermis (AteloCell, KOKEN,
Japan), following a previously standardized protocol [16]
with some modifications. Briefly, type I collagen (4 mg/
ml), 1x Dulbecco’s modified Eagle medium (DMEM 10x,
Sigma-Aldrich, Germany) or 1x phosphate-buffered sa-
line (PBS 10x, Lonza, Switzerland) were mixed on ice,
and then the pH was carefully adjusted to 7.4 ± 0.2 using
sterile sodium hydroxide (Sigma-Aldrich). Subsequently,
the gels were polymerized at 37 °C for 30 minutes.
The glycated gels were prepared using a non-enzymatic
post-glycation method to modify the biomechanics prop-
erties of collagen. Ribose (D-Ribose, Sigma-Aldrich) was
used to glycate the matrices according to the literature
[19–22]. After gels polymerization, different ribose con-
centrations (0, 30 and 240 mM) were added in the media
(day 0), which were not changed until the fifth day to
allow cross-linking between the collagen and the reducing
sugar to occur [19–21, 27]. Then, medium without ribose
was used, which was changed every two days for twenty-
one consecutive days.
Physical characteristics of the non-cellular post-glycated
three-dimensional matrix
Confocal reflectance collagen imaging
Collagen gels under all of the ribose conditions were pre-
pared in 35 mm glass-bottom culture dishes (MatTek,
USA). The collagen structure was examined using con-
focal reflection microscopy (CRM) as reported elsewhere
[29]. In brief, reflection fluorescence of collagen fibers
were visualized by exciting the collagen gels using a
568 nm laser and collecting the reflected signal of the
same wavelength. Images were acquired on the 7th, 14th
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focal laser-scanning microscope (D-Eclipse C1, Nikon,
Tokyo, Japan) coupled to an EM-CCD digital camera
(C9100, Hamamatsu, Japan) equipped with an ELWD
60×/0.70 objective (Nikon, Tokyo, Japan) using Meta-
morph software (Molecular Devices, USA). The same
image acquisition parameters were used for all of the gels
at each time point. The images were analyzed using Image
J program [30].
Advanced glycation end products (AGEs)
Different experimental conditions were used to produce
the post-glycated DMEM and PBS three-dimensional colla-
gen matrices as follows: ribose at 0, 5, 15, 30 or 240 mM
and Fetal Bovine Serum (FBS) at 0, 1 or 10 % was added to
the media on the day 0. The level of fluorescent advanced
glycation end products (AGEs) generated in collagen matri-
ces was determined by an indirect measure in dark 96-well
sterile plates (Nunc, Denmark) using a FLUOstar OPTIMA
plate reader (BMG Labtech, Germany) at ex/em: 360/
440 nm wavelength [20, 21, 27, 28, 31, 32], on the 1st, 7th,
14th and 21st days post-polymerization. The level of matri-
ces and media autofluorescence was individually analyzed.
Gel mechanical measurements by atomic force microscopy
(AFM)
Post-glycated 3D collagen matrices were elaborated as ex-
plained above using the same conditions of collagen fibers
configuration (confocal reflectance imaging). The ribose-
induced mechanical alterations in the collagen gels were ex-
amined on the 7th, 14th and 21st days by assessing their
Young’s elastic modulus, E, which is indicative of gel’s re-
sistance to deformation. E was measured using a stand-
alone AFM (Bioscope, Veeco, USA) coupled to an inverted
optical microscope as previously described [33]. Briefly, the
AFM measurements were taken using low spring constant
cantilevers with pyramidal tips (nominal k = 0.01 N/m)
(Microlever, Veeco), which were calibrated using the ther-
mal noise method [34]. For each gel location, three force
vs. piezo displacement curves (F-z curves) were acquired
using a moderate loading force (~1 nN). For each gel loca-
tion, E and the extent of gel indentation (d) were computed
as the averages of the values obtained by least-squares fit-
ting of a contact elastic model to each set of three F-z
curves, as reported elsewhere [35]. The same protocol was
applied on at least 9 random gel locations. For each treat-
ment, the E data were normalized using the corresponding
value obtained from 0 mM ribose gel at the 7th day.
Effects of post-glycated matrices on primary human
normal lung fibroblasts
Ethics Statement
This study involved the analysis of human clinical sam-
ples. Normal human lung tissues were obtained fromlung biopsies from patients with pneumothorax and no
history of tobacco use, diabetes mellitus or any other
pathology and that were histologically normal and without
infection. Informed written consent was obtained from all
patients. The investigation project and protocol were ap-
proved by the Ethics Committee of our center (ref. PR202/
08, CEIC, Institute of Investigation of Bellvitge (IDIBELL),
Barcelona, Spain).
Cell culture
The primary human normal lung fibroblasts were iso-
lated from lung biopsies, following the standard methods
described in the literature [36]. Briefly, 1 mm2 fragments
of tissue were incubated under sterile conditions in
DMEM supplemented with 10 % FBS (Gibco, UK),
100 IU/mL penicillin (Gibco), 100 μg/mL streptomycin
(Gibco) and 2 μg/mL amphotericin B (Sigma-Aldrich).
The fibroblasts cultures were maintained in a 5 % CO2
humidified atmosphere at 37 °C. After two-three weeks
of culture cells were attached to the plate. Unattached
cells were eliminated by changing the media. When reach-
ing the confluence, the morphology of cells were fibroblasts
type, and resulted positive for vimentin and negative for
alpha-sma markers, indicating the mesenchymal origin
(Additional file 1). Fibroblasts were then trypsinized (0.05 %
trypsin-EDTA, Gibco) and cryopreserved using standard
methods and used at passages (3–5) for culturing within
the post-glycated matrices.
Fibroblasts culture within the post-glycated
three-dimensional collagen type I matrices
Type I collagen matrices were prepared as explained before.
The primary normal fibroblasts were added and mixed with
the collagen before polymerization of the gel. Cells were
cultured in 3D post-glycated DMEM collagen matrices in
sterile 96-well plates (TPP, Switzerland) at an initial concen-
tration of 15x103 cells/gel. After polymerization of the
matrices, media with different concentration of ribose and
FBS was added (5, 15, 30 and 240 mM of ribose and 0, 1
and 10 % of FBS). Cell viability and phenotype changes
were evaluated on the 7th, 14th and 21st days of culture.
Analyze of cell viability was adjusted to day 1 and the re-
sults were shown since the 7th day to allow cell stabilization
and adaptation into the glycated 3D gels. The results were
evaluated from the 7th day at different time-points and con-
ditions because until the 5th day the media was not changed
to permit collagen cross-links.
Fibroblast viability
The viability of the fibroblasts growing within the post-
glycated 3D collagen type I matrices was assessed using a
metabolic test (AlamarBlue assay, Invitrogen, UK) and a
staining method that distinguishes viable and non-viable
cells (LIVE/DEAD viability/cytotoxicity kit, Invitrogen) on
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recommendations. The AlamarBlue assay, which is nor-
mally used in 2D cultures, required preliminary tests for
use in the 3D collagen matrices. After testing AlamarBlue
at several concentrations and incubation times for twenty-
one days, incubation time of 8 h and concentration of 1/
10 were used in all viability experiments. Then, the assay
was conducted according to the manufacturer’s recom-
mendations. The cell fluorescence was measured using
a microplate reader (FLUOstar OPTIMA, BMG Lab-
tech) at ex/em: 550/590 nm wavelengths. The LIVE/
DEAD viability/cytotoxicity reagents stain viable cells
in green (Calcein acetoxymethyl ester; Ca AM (ex 495/
em 515 nm wavelengths)) and non-viable cells in red
(ethidium homodimer-1; Eth-D1 (ex 495/em 635 nm
wavelength). Images of stained sections were acquired
using a Leica TCS-SL filter-free spectral confocal laser
scanning microscope (Leica Microsystems, Mannheim,
Germany) equipped with a 488 nm argon laser using a
10x dry objective (0.3 numerical aperture). Three-
dimensional image assembly was performed using the
fiji-win32 program (Image J). The cells were typified as
live or dead using manual counting by two observers.
An additional movie shows the cellular distribution in
3D-matrices after stained with Calcein and Ethidium
stains (see Additional file 2). An additional image of fi-
broblasts morphology, when they are cultured into the
DMEM and PBS matrices at different FBS concentra-
tions (0, 1 and 10 %), is available as Additional file 3.
α-smooth muscle actin gene expression
RNA extraction was performed using the
guanidiniumthiocyanate-phenol-chloroform method
(TRIzol, Invitrogen), according to the manufacturer’s
recommendation. First, the matrices were placed in
TRIzol Reagent and disrupted using a tissue homogenizer.
To eliminate the genomic DNA, the RNA was treated
with DNAse I (Invitrogen). One microgram of total RNA
was reverse transcribed to cDNA using a High Capacity
cDNA Reverse Transcription kit (Applied Biosystems,
UK). α-smooth muscle actin (α-SMA) gene expression
was evaluated using real-time quantitative reverse
transcription-polymerase chain reaction (qPCR) with the
TaqMan Gene Expression master mix (7900 HT, Applied
Biosystems). The results were analyzed by the ΔΔCt
method, normalized with two endogenous housekeeping
genes (Eukaryotic 18S rRNA, 18S and DNA-directed RNA
polymerase II, RPII).
α-smooth muscle actin Western Blot
Protein extraction from the matrices was performed ac-
cording to the Heidebrecht protocol with few modifica-
tions [37]. The matrices were rinsed with iced-cold PBS,
and the total cellular protein extracts were preparedusing a radioimmunoprecipitation assay buffer (RIPA,
Sigma-Aldrich) containing phosphatase and protease in-
hibitor cocktail (Sigma-Aldrich); the samples were soni-
cated and then frozen at −80 ° C until protein
quantification was performed. Prior to performing the
protein quantification, a 2-D clean-up (GE Healthcare
Life Science, Germany) was conducted. Protein quantifi-
cation was performed using a BCA Protein Assay Re-
agent (Thermo scientific, Germany) following the
manufacturer’s instructions. Thirty micrograms of pro-
tein extract was loaded to SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE, Mini-PROTEAN® TGX™ gels,
Bio-Rad Laboratories, USA). The proteins were trans-
ferred to Trans-Blot® Turbo™ Mini Nitrocellulose Trans-
fer Packs (Bio-Rad) using a Trans-Blot® Turbo™ Transfer
Starter System (Bio-Rad). The membranes were blocked
using 5 % BSA (bovine serum albumin, Sigma-Aldrich)
in TBST (Tris-buffered saline with 0.1 % Tween 20) for
1 h; incubated with the primary antibodies: α-SMA
(1:500, Sigma-Aldrich) and α-tubulin (1:1000, Sigma-
Aldrich) for 1 h and finally incubated with a secondary
anti-mouse IgG antibody conjugated with horseradish
peroxidase (1:1000, HRP, Dako, Denmark) for 1 h at
room temperature. After each antibody incubation step,
the membranes were washed three times using TBST for
10 minutes each. The bands were visualized with en-
hanced chemiluminescence using Clarity™ Western
ECL Substrate (Bio-Rad), and images were captured
using a LAS-3000 Imaging System (Fujifilm Holdings
Corporation, Japan). As a band of 66 KDa was always
present in cellular and acellular matrices, an incuba-
tion with the three primary antibodies together for
1 h (bovine albumin (1:8000, Abcam), α-SMA (1:500,
Sigma-Aldrich) and α-tubulin (1:1000, Sigma-Aldrich))
was performed confirming that the band observed at
66 KDa was albumin, probably due to the difficulties
in rinsing all the media with FBS contained in the
matrices prior to protein extraction (data not shown).
Western blot densitometry was performed using Multi-
Gauge image software (Fujifilm) by normalizing the values
for α-SMA expression to the respective value of α-tubulin
for each sample.
Tenascin-C expression
To assess the expression of the pro-fibrotic protein
Tenascin-C (TNC) produced by fibroblasts, an ELISA
using a Human Tenascin-C Large Assay Kit (FN III-C,
IBL International, Germany) was performed following
the manufacturer’s instructions.
TNC was evaluated from the supernatants of the
DMEM matrices when gel contraction was observed (i.e.
when 10 % of FBS was used). The precoated plate was
read in Multiskan EX (Thermo Scientific, USA) and
measured at 450 nm.
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The data are expressed as the mean values ± SD from
three independent experiments. Differences between the
control and experimental conditions were assessed using
different tests. Data with non-normal distribution were
analyzed using non-parametrical Mann–Whitney U and
Kruskal Wallis tests. When the data attained a normal
distribution, Student’s t-test, a two-way ANOVA, a
multivariate ANOVA and a linear regression test were
used. To evaluate the cell viability data, a mixed linear
model was used. Statistical significance was considered
when the p value was less than 0.05. We performed the
analyses using SPSS 15.0 software (IBM SPSS statistics,
USA). For the calculations regarding cell viability, free
statistical software was used (www.r-project.org) with
the nmle package for the mixed linear models.
Results
Physical characteristics of the non-cellular post-glycated
three-dimensional
Using CRM we examined the morphological and struc-
tural modifications of type I collagen post-glycated fibers
(reflection fluorescence). Different changes occurred de-
pending on the medium used in the preparation of the
matrices (DMEM or PBS). DMEM matrices exhibited
large, thick fibers that formed aggregates (Fig. 1a), while
PBS matrices displayed short, thin collagen fibers with
no evidence of aggregation (Fig. 1b). An increased inten-
sity of collagen reflection fluorescence was observed in all
the DMEM matrices with the highest ribose concentration
(240 mM). However, this phenomenon did not occur in
PBS matrices. This different reflection fluorescence inten-
sity in DMEM and PBS matrices was attributed toFig. 1 Increased collagen type I fiber reflection fluorescence with non-enzy
CRM (laser ex/em 568/568 nm) at different ribose (R) concentration over a per
I fibers formed aggregates and reflected more fluorescence with elevated R c
short, thin and homogeneous, with no increase of reflected fluorescence with
non-glycated matrices (controls) was done to the reflective properties of the c
The increase in CRM signal in DMEM gels could also be contributed by the in
because the presence of glucose. The scale bar corresponds to 40 μm. CRM=
medium; PBS = Phosphate-buffered salinedifferent pattern of collagen fibers organization depending
on the substrate used (DMEM or PBS).
To indirectly assess the extent of AGEs formation,
we measured the autofluorescence intensity of DMEM
and PBS matrices with different FBS concentrations
at the wavelength of fluorescent AGEs (ex/em 360/
440 nm) by a plate reader as described in the litera-
ture [20, 21, 27, 28, 31, 32]. As shown in Fig. 2 (a
and b), the content of AGEs increased gradually in a
ribose concentration-dependent manner in both con-
ditions, DMEM and PBS (p < 0.05), independently of
the serum concentration (p > 0.05). The highest value
was found at the highest ribose concentration
(240 mM, p < 0.01). An autofluorescence peak was
found at 7th day (p < 0.01) in all conditions. Then,
less autofluorescence was observed for all the matri-
ces at day 14 and 21, probably due to a decreased
amount of AGEs formation after changing the media
every 2 days. Interestingly, autofluorescence measure-
ments revealed that DMEM matrices (Fig. 2a) were
more autofluorescent than PBS matrices (Fig. 2b) at
days 1 and 7 (p < 0.05 in practically all conditions).
Nevertheless, PBS matrices became more autofluorescent
than DMEM ones after the 14th day (statistically signifi-
cant in practically all conditions for FBS 1 % and 10 %).
Because the accumulation of AGEs generated by non-
enzymatic glycation induces modifications and cross-links
that stiffen human tissue proteins [22, 25], we examined
using the mechanical changes in glycated matrices at the
micrometer scale by measuring the Young’s elastic modu-
lus (E) through AFM (Fig. 3). The E value of the control
gels (0 mM ribose) at day 7 was 1.6 ± 0.3 and 0.9 ± 0.5 kPa
in DMEM and PBS post-glycated matrices (0 % FBS),matic glycation. Collagen type I fiber conformation observed with
iod of twenty-one days. a. In post-glycated DMEM matrices, collagen type
oncentrations. b. In post-glycated PBS matrices, collagen type I fibers were
higher R concentration (240 mM). a and b. Reflection fluorescence of
ollagen. Time seems to not affect the reflection fluorescence of collagen.
creased aggregation of collagen fibers observed in these gels, perhaps
Confocal reflection microscope; DMEM=Dulbecco’s modified Eagle
Fig. 2 The formation of advanced glycation end products (AGEs) increased with collagen glycation. AGEs formation was evaluated in non-cellular
post-glycated DMEM (a1-3) and PBS (b1-3) matrices based on autofluorescence (ex/em: 360/440 nm wavelengths). The matrices were elaborated
using different concentrations of fetal bovine serum (FBS), 0 % (a1, b1), 1 % (a2, b2) and 10 % (a3, b3). The media was changed every 2 days beginning
on the 5th day to allow collagen cross-linking to occur. AGE formation in both type of matrices (DMEM and PBS), was significantly greater with higher
ribose concentrations (240 mM) (p < 0.01) and at the 7th day (p < 0.01). After that, less autofluorescence was observed for all the matrices suggesting less
AGEs’ formation. Interestingly, DMEM matrices (2A) were more autofluorescent than PBS matrices (2B) at days 1 and 7 (p < 0.05 in practically all conditions).
Nevertheless, PBS matrices became more autofluorescent than DMEM ones after the 14th day (p < 0.05 in practically all conditions for FBS 1 % and 10 %).
The experiments were repeated three times with similar results obtained. * p < 0.05
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the corresponding control values at day 7. Our results re-
vealed that both DMEM and PBS matrices stiffened in a
ribose-dependent manner with respect to the control non-
glycated gels (p < 0.01). The highest value of stiffness was
reached at day 21st for PBS matrices as shown in Table 1
(absolute E value: 2.5 ± 1.35 KPa). Nonetheless, the max-
imum point of stiffness was not always at the end of the
experiment. Fold stiffness in DMEM gels remained rather
unaltered after day 14th. In contrast we observed a moder-
ate rise in fold gel stiffness in PBS gels up to 21st day
(Fig. 3a and b). Consequently, stiffness of the matrix wasgreater after the 14th day of post-polymerization. However,
the basal stiffness values in control gels (0 mM ribose) at
day 7th were higher in DMEM than in PBS gels, perhaps
because of glucose present in DMEM.
Effects of post-glycated matrices on primary human
normal lung fibroblasts
Fibroblast viability
The fibroblast viability in the glycated 3D collagen matri-
ces at different FBS concentrations was determined quan-
titatively using the AlamarBlue assay, which assesses the
extent of mitochondrial activity via fluorescence (redox
Fig. 3 Collagen post-glycation increased the matrix stiffness. The stiffness of the non-cellular post-glycated matrices was measured using atomic
force microscopy at days 7, 14 and 21. The values were normalized using that of the non-glycated matrices, i.e. control matrices (0 mM of ribose
(R)) at the 7th day. The black arrows indicate the R concentration that rendered the collagen gels stiffer than the non-glycated gel at the 7th day.
a. DMEM matrices. Collagen gels stiffened in a R dependent manner at the 14th day after glycation at 30 and 240 mM of ribose respect to the
control non-glycated gels (p < 0.01). b. PBS matrices. The collagen gels stiffened with 240 mM of ribose at the 21st day after glycation (p < 0.01). a
and b. This different stiffening dynamics suggests different cross-linking rates between these gels. The glucose present in DMEM could play a role
in the stiffness developed, which could render a higher basal level of glycation before ribose treatment. Accordingly, the non-glycated DMEM gels
(controls) showed greater stiffness than the glycated matrices at the 7th day. Phenomenon not observed in PBS matrices. The highest R concentration
(240 mM) led to the stiffest conformation of both types of matrices (p < 0.01). p-values for 30 mM of ribose: + (0.01 < p < 0.05), ++ (p < 0.01); p-values
for 240 mM of ribose: *(0.01 < p < 0.05), ** (p < 0.01)
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tial staining of live and dead cells visualized using confocal
microscopy (Fig. 4b).
In our study, the fluorescence intensity data revealed a
marked decrease in fibroblast viability at the highest ri-
bose concentration (240 mM) under all of the gel condi-
tions independently of the substrate FBS content (p <
0.01) (Fig. 4a and b), suggesting a cytotoxic effect of ri-
bose at high concentration. Nevertheless, cells prolifer-
ated and survived during 21 days of culture with 5, 15
and 30 mM ribose concentration when 10 % of FBS was
used (Fig. 4 a3). No statistical differences in cell viability
were observed respect to the control, 0 mM ribose when
0 % of FBS was used (p > 0.05), nor for 1 % too (p > 0.05).
A strong effect on cell growth was observed when com-
paring fibroblasts cultured in matrices with serum with
matrices without serum over the period from the 7th to
the 21st day, which was independent of the ribose concen-
tration (p < 0.01 for 1 % and 10 % FBS, respectively).
On the other hand, to confirm the results of cell via-
bility and avoid the possible effect of the reducing sugarto the redox reaction of the AlamarBlue assay, data from
non-cellular matrices were analyzed (Additional file 4).
Results showed that the fluorescence intensity from non-
cellular matrices was significantly higher at 240 mM of ri-
bose concentration (p < 0.01) and was independent of the
use of serum (p > 0.05) (Additional file 4). Therefore, the
observed increase in the fluorescence of the cellular matri-
ces depended on the cell viability, which increased with
serum. Then, the best conditions for allowing cell to grow
inside the glycated collagen gels up to 21 days are at 5 and
15 mM of ribose and 10 % of FBS.
In addition, images taken using a CRM confirmed
that the cells had proliferated, with an increase in the
number of viable cells when FBS and low ribose con-
centrations were used (Fig. 4 b2 and b3) and that
cells died with the highest ribose concentration from
the first days (data shown in Fig. 4 b1-3 from the 7th
day). Moreover, matrix contraction was observed in
the lattices with increased cell growth (<15 mM ri-
bose and 10 % FBS) between the 14th and 21st days
of culture (Fig. 4 b3).
Table 1 Summary results from the post-glycated three-dimensional collagen matrices
Types matrices PBS DMEM
Fiber collagen I reflection fluorescence
(ex/em: 568/568 nm)
Short, thin, homogeny collagen fibers with no evidence
of aggregation nor increment of reflection collagen
fluorescence.
Large heterogenic thick fibers that formed aggregates. Increase of reflection
collagen fluorescence at higher ribose concentration.
Stiffness (absolute
values, KPa +/− SD)
7th day 0 mM 0.9 +/− 0.5 1.6 +/−0.3
14th day 30 mM 0.47 +/− 0.31 1.33 +/− 0.51
240 mM 1.17 +/−087 1.71 +/−0.72
21st 30 mM 0.97 +/−0.16 0.53 +/−0.21
240 mM 2.5 +/−1.35 1.03 +/−0.43
Viability AlamarBlue Assay
Fluorescence (ex/em:
550/590 nm)
Data not shown
[Ribose] [Ribose]
240 mM→ cell death 240 mM→ cell death
≤30 mM→↑ mitochondrial metabolism ≤30 mM→↑ mitochondrial metabolism
Confocal Reflection
Microscopy, live/dead assay
(green/red stain)
Data not shown
[Ribose] [Ribose]
240 mM→ cell death 240 mM→ cell death
≤30 mM→ Better viability (green stain) ≤30 mM→ Better viability (green stain)
Cell morphology: round, stellar, short dendritic cells
(See Additional file 3).
Cell morphology: spindle, long dendritic cells (See Additional file 3).
Gel contraction Data not shown
[Ribose] [Ribose]
Controls (0 mM): from 14th day
5 mM and 15 mM: Between 14th and 21st days of culture.
5 mM, 15 mM and controls (0 mM): between 14th and 21st day of culture.
AGEs autoflorescence
(ex/em: 360/440 nm)
At ↑[Ribose]→ autofluorescence increase. At ↑[Ribose]→ autofluorescence increase.
Higher autofluorescence at the 14th and 21st day compared
with DMEM matrices (*).
Higher autofluorescence at the 1st and 7th day compared with PBS matrices (*).
Protein synthesis α-smooth muscle actin
(α-SMA)
NA Gene expression (21st day): at 5 (*) and 15 mM of [Ribose] and controls.
Protein expression (14th and 21st days): in all conditions, particularly with 5 and
15 mM of [Ribose].
Tenascin-C (TNC) NA Protein expression: ↑ in a time-dependent manner at 14 and 21 days (*).
PBS phosphate-buffered saline, DMEM Dulbecco’s modified Eagle medium, Ex/em Excitation/Emission, nm nanometers, KPa KiloPascals, SD Standard deviation, mM miliMolar, N/A Not Available, [Ribose] concentration
of ribose; ↓: decreased; ↑: elevated; ≤: minor or equal; (*) p < 0,05
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Fig. 4 Post-glycated matrices support fibroblast viability for long periods. Primary human lung fibroblasts cultured within different glycated
collagen DMEM matrices over a period of 21 days. a. Fluorescence determination using alamarBlue assay. b. LIVE/DEAD viability/cytotoxicity
stained cells observed using confocal reflection microscopy. The viable cells are stained green, and the non-viable cells are stained red. a and b.
Cell death occurred under all conditions at the highest ribose (R) concentration (240 mM), independently of the use of serum (FBS). The use of
FBS increased the proliferation rate under the rest of the conditions (p < 0.01). a1 and b1 (0 % FBS). No cell proliferation was observed, but cells
were alive during the 21 days. a2 and b2 (1 % FBS). A gradual increase in cell proliferation was observed under all conditions except R 240 mM,
but the rates for R 5 mM (p < 0.05) and the control matrices (p < 0.01) were significantly different only between the 7th and 21st days. a3 and b3
(10 % FBS). An improved proliferation rate was observed with the use of 10 % of serum, which was significantly for the control (non-glycated)
only between the 7th and 14th days (p < 0.05). Gel contraction was observed in ≤15 mM R conditions between the 14th and the 21st day. No gel
contraction was observed at 30 mM R (explanation in discussion). It was not possible to determine the fluorescence in the controls and in matrices
glycated using 5 mM R at the 21st day because of gel contraction and cells growing on the bottom of the well (a3). The scale bars correspond to
200 μm. The experiments were repeated three times, with similar results obtained
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To evaluate the putative differentiation of fibroblasts to
a contractile cell phenotype (myofibroblasts-like), which
could contribute to the contraction of the post-glycated
DMEM matrices α-smooth muscle actin (α-SMA) gene
expression and α-SMA protein levels were examined.
Only contracted matrices were evaluated, i.e. those with
10 % FBS. The cells growing on the bottom of the petri
dishes were not analyzed (Fig. 4 b3).A higher increase of α-SMA gene expression was ob-
served in 0–15 mM of ribose at the 21st day (Fig. 5). α-SMA
protein detection appeared from day 7th in all conditions,
with and without ribose, and was significantly increased at
days 14 and 21 compared to the 7th day (p < 0.01), which
suggests that the induction of α-SMA is modified by the 3D
microambient ‘per se’ (Fig. 6).
The supernatants of the DMEM matrices from three
independent experiments were analyzed to evaluate the
Fig. 5 Post-glycated matrices induce a contractile phenotype. Primary
human normal lung fibroblasts cultured within three-dimensional
glycated DMEM matrices with 10 % of serum were analyzed to
determine the level of alpha-smooth muscle actin (α-SMA) gene
expression at the 7th, 14th and 21st day of culture. α-SMA gene
expression was observed in the glycated matrices prepared with
5 mM, 15 mM ribose (R) and in the non-glycated matrices (controls)
on the 21st day (only statistically significant (p < 0.05) for 5 mM).
This phenomenon corresponded to the occurrence of gel contraction.
In contrast, α-SMA gene expression and gels contraction were not
observed in the 30 mM R glycated matrices on the 21st day. Interestingly,
a progressive increase of α-SMA gene expression was observed with a
gradual increase of R on day 7th, suggesting that the differentiation of
fibroblasts to a contractile phenotype depends not only on time but also
on the ribose concentration, which is associated with the extent of
collagen cross-linking. The data are presented as percentages respect
to the values on the 1st day. The experiments were repeated three
times, with similar results obtained. * p-value < 0.05
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Results showed a progressive increase in the secretion of
TNC in all the matrices from the 1st to the 21st day, with
statistical differences between the 1st and the 14th day
and the 1st and the 21st day (p < 0.05 for both compari-
sons). Although no differences were appreciated between
the 14th and the 21st day of culture in most ribose condi-
tions, a higher level of TNC at the 21st day was observed
with 30 mM of ribose (p = 0.08). No statistical differ-
ences were found between ribosilated and non-
ribosilated matrices. These results suggest that the 3D
microenvironment could be enough to produce changes
in the secretion of TNC by normal fibroblasts in a time-
dependent manner.
Discussion
Lung tissue fibroblasts are normally surrounded by a 3D
ECM and the interaction between fibroblasts and ECM
proteins could be crucial in tissue homeostasis and dis-
ease. However, most in vitro studies in lung fibrosis have
been performed with fibroblasts growing in a plate (2D)
or in 3D based on polyacrylamide hydrogels [8, 38, 39]
or collagen type I gels [17, 18, 27, 40] with fibroblasts
growing on top. Few studies have analyzed the viability of
fibroblasts growing within type I collagen matrices [7, 41].Our study was designed to modify the 3D collagen matrix
via non-enzymatic glycation and to analyze the impact of
such matrices on fibroblast phenotype and viability grow-
ing inside the gel. To our knowledge, there are no previ-
ous reports of analyzing fibroblasts viability in glycated
DMEM matrices by using two corroborating cell growth
methods. We used ribose as a reducing sugar rather than
glucose due to the ability of ribose to modify faster the
physical and chemical properties of type I collagen gels
[21]. Very few studies have used post-glycated collagen
matrices with cells growing inside, and none in the field of
lung fibrosis [19, 21]. Our novel 3D culture model dis-
played collagen enrichment and an aging/oxidative micro-
environment with increased stiffness, which may be useful
for the study of cell behavior and phenotypic changes that
depend on pro-fibrotic ECM conditions. Our study points
up the best three-dimensional ribosilated matrices condi-
tions to allow primary lung fibroblast viability and growth.
Furthermore, the results demonstrate that the 3D collage-
nated matrices induce fibroblast-to-contractile phenotype
differentiation and an increase of TNC synthesis. We ob-
served structural differences in the collagen fibers depend-
ing on the medium used in the preparation of the
matrices (DMEM or PBS), which may be attributable to
the presence of glucose in DMEM. Our results showed
that once the matrices have been glycated, the higher ri-
bose concentrations (240 mM) increased the reflectance
fluorescence of collagen type I in DMEM matrices (Fig. 1)
and the AGEs production (Fig. 2) in agreement with previ-
ous published results [20, 21, 27]. However, the ribose-
dependent increase in CRM signal in DMEM gels could
also be contributed by the increased aggregation of colla-
gen fibers observed in these gels, which could locally en-
hance the reflective properties of the collagen. In contrast,
such structure-related differences observed by CRM may
not contribute to the autofluorescence measured by the
plate reader or to the stiffness results.
The interest of using glycated collagen gels was to re-
semble the increased stiffness observed in aged and fi-
brotic lungs [2, 42]. Furthermore, the use of the post-
glycation method (instead of pre-glycation technique)
aimed to approach to the collagen cross-links, which
could occur in vivo. Some studies have used non-
enzymatic glycation to create stiffer scaffolds with in-
creased mechanical rigidity but none concerned to lung
fibrosis [20, 21, 27, 43]. Our results demonstrated that
the glycation process stiffened the collagen matrices in a
concentration-dependent manner, occurring earlier in
the DMEM matrices than in the PBS matrices. To our
knowledge, we provide first evidence that glycation-
induced collagen gel stiffening depends not only on ribose
concentration, but also on the type of substrate solution
used (DMEM or PBS). However, these different stiffening
dynamics, suggests different cross-linking rates between
Fig. 6 α-SMA protein detection in the 3D matrices. alpha-smooth muscle actin (α-SMA) protein expression in the primary human normal lung
fibroblasts was evaluated using western blot. Fibroblasts were cultured within 3D glycated DMEM matrices containing 10 % serum. a. Western
Blot. α-SMA band, 42 kDa; α-tubulin band, 50 kDa. Albumin band (66 kDa, due to FBS and visible in cellular and acellular matrices blots’, probably
because of the difficulty in rinsing all the media from the matrices prior to protein extraction). The experiments were repeated three times. a1.
An insignificant amount of α-SMA was detected in all the cellular matrices. a2 and a3. Higher amounts of α-SMA were observed in all the cellular
matrices on the 14th and 21st days of culture. a1, a2 and a3. No tubulin or α-SMA bands were detected in the non-cells matrices. b. Densitometric
analysis of α-SMA levels (Ratio of α-SMA to α-tubulin). The results were obtained from three independent experiments. *p < 0.05, **p < 0.01. A gradual
decrease of α-SMA was observed at higher ribose concentrations on the 7th day of culture (p > 0.05). Contractile phenotype was most strongly detected
on the 14th and 21st days of culture. It was significantly higher at all ribose concentrations, also for controls without ribose, compared with the level on the
7th day. It suggests that the microambient ‘per se’ could induce a phenotype change and that cells contribute to the matrix contraction
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to the glucose already present in DMEM, which could
render a higher basal level of glycation before ribose treat-
ment and to the diameter and length of the cross-linked
collagen fibrils [42]. In support of this hypothesis, the
basal stiffness values in control gels (0 mM of ribose) at
day 7th were higher in DMEM than in PBS gels. Our stiff-
ness values were similar to those reported by Roy et al.
[20], and slightly higher than those from other authors
without cells [27, 43], most likely because of differences in
the experimental conditions, such as the method of meas-
ure. In contrast, when cells were cultured within the gly-
cated matrices, an elevated Young modulus was observed
[19, 21]. Interestingly, a recent study by Booth et al. [14]
showed an increased stiffness of decellularized fibrotic
lungs compared with normal lungs, plausibly attributed to
the substantial and varied amounts of pro-fibrotic ECM
proteins present in the former in addition to collagen.
Thus, it is conceivable that cells embedded into the colla-
gen gels would also upregulate the expression of other
interstitial proteins, increasing the rigidity of the gel,
which will be the focus of future in vitro studies [3, 42]. As
a preliminary data, the fibroblasts growing inside our 3D
collagen matrices increased the synthesis of TNC, a pro-
fibrotic ECM protein. This phenomenon occurred in a
time-dependent manner, independently of the riboseconcentration. However, the level of TNC was higher in
30 mM ribosilated matrices at the 21st day, suggesting that
TNC synthesis by normal fibroblasts was dependent on
the cell-type I collagen interactions and also on the indir-
ect effect of ribose on collagen (stiffness, AGEs or collagen
cross-links). These observations leads to further studies in
order to better explain this effect.
Importantly, the non-enzymatic glycation of collagen
resulted in the formation of AGEs, which are related to
aging and have been observed to stiffen tissues in differ-
ent degenerative diseases [22–25]. With age, collagen be-
comes less soluble [26], more cross-linked and more
glycosylated [5]. In studies of aged collagen fibers from
different tissues, such as skin and lungs, the presence of
AGEs was detected indirectly as an increase in the colla-
gen autofluorescence [31, 32]. Our results showed that
the change in the autofluorescence of glycated collagen,
measured with the specific wavelength of fluorescent
AGEs as reported elsewhere [20, 21, 27, 28, 31, 32], was
dependent on the formation of AGEs (Fig. 2). Further-
more, we have shown that the collagen autofluorescence
was affected by the ribose concentration in a dose-
dependent manner, with fluorescence increasing when
the highest ribose concentration was used. In support of
our findings, other groups have reported that the fluores-
cence of glycated collagen matrices gradually increased with
Fig. 7 3D matrices induce Tenascin-C synthesis in lung fibroblasts. Levels of Tenascin-C (TNC) were measured from the supernatants of the 3D
DMEM matrices by ELISA. The results were obtained from three independent experiments. Fibroblasts were cultured with 10 % of FBS. The synthesis of
TNC was induced in a time-dependent manner, observing significant statistical differences between the 1st and the 14th and 21st days of culture
(p < 0.05 for both comparisons). Although no differences were appreciated between the 14th and the 21st days of culture, a higher level of TNC was
observed with 30 mM of ribose at the 21st day (p = 0.08). No statistical differences were observed between glycated and non-glycated matrices. These
results suggest that the 3D microenvironment could be enough to produce changes in the secretion of TNC by normal fibroblasts in a
time-dependent manner
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of the carbohydrate used for glycation [20, 21, 27].
On the other hand, a peak of autofluorescence was al-
ways observed at 7th day and then the autofluorescence
decreased (days 14th and 21st), probably because less
new AGEs formation after day 7th. It could be a conse-
quence of the technical approach, since the media was
not changed until the 5th day after post-glycation and
then it was changed every two days. This phenomenon
could be attributed to the rinse of the matrices with the
changes of the media, which would attenuate the forma-
tion of new cross-links between the glucose and the col-
lagen. Another possibility would be that the cross-links
could be higher at the beginning of the post-glycated
matrices reaction. Additionally, our experiments of auto-
fluorescence in PBS and DMEM matrices revealed dif-
ferent cross-linking rates. As DMEM matrices (Fig. 2a)
showed more autofluorescence than PBS matrices
(Fig. 2b) at days 1 and 7, less autofluorescence from
DMEM compared to PBS matrices was observed since
the 14th day. These different cross-linking rates could
explain the differences in stiffening dynamics between
those gels (DMEM and PBS). In agreement with these
dynamics, fold stiffness in DMEM gels remained ratherunaltered after day 14th. In contrast we observed a mod-
erate rise in fold gel stiffness in PBS gels to the 21st day.
One of the main findings in the present study was the
demonstration of the profound effect of the physical and
chemical changes of the three-dimensional matrices on
the fibroblast phenotype and cell growth. We demon-
strated that fibroblasts embedded in the matrices con-
taining low ribose concentrations (≤30 mM) were able
to proliferate and that the better growth rate was ob-
served using FBS, whereas significant cell mortality was
observed in matrices with highest ribose concentration
(240 mM) independently of the use of FBS (Fig. 4), most
likely because of the increased osmosis [19]. Remarkably,
we detected a contractile cell phenotype expressing
alpha-smooth muscle actin (α-SMA). This occurrence of
the contractile phenotype was related to the contraction
of glycated gels using 5 and 15 mM of ribose and to that
of the non-glycated matrices between the 14th and 21st
days, when 10 % of serum was used (Fig. 4 b3). Remark-
ably α-SMA was induced without adding TGFβ1, sug-
gesting that the microenvironment ‘per se’ modifies cell
phenotype by increasing cell contractility. Therefore,
the experiments of expression and detection of α-SMA
as a contractile phenotype marker (Figs. 5 and 6,
Vicens-Zygmunt et al. Respiratory Research  (2015) 16:82 Page 13 of 15respectively), were performed only in the matrices
where the gel contraction was observed, (i.e. when 10 %
of FBS was used), to verify if the cells embedded into
the matrices could contribute to their contraction.
Therefore, it is important to emphasize two messages:
1) the induction of α-SMA expression and protein level
is modified by the microambient and 2) cells contribute
to the matrix contraction.
The mechanisms by which cells contract the collagen
gels are unclear. Based on previous studies, it is conceiv-
able that as matrix stiffness increases, the fibroblasts de-
velop proportional isometric tension, acquiring
prominent actin stress fibers that cause the contraction
of the matrices [3, 5, 7, 17, 44, 45]. Nevertheless, fibro-
blasts that do not surmount the tension of the matrix
also develop actin stress fibers, but they do not contract
the lattice [7, 17]. This attribute is relevant to the differ-
ences found in α-SMA detection and the contraction of
our gels depending on the ribose concentration, as oc-
curs with 30 mM of ribose [7, 44]. In those matrices, the
contractile phenotype, α-SMA positive (Fig. 6 a2 and
a3), did not contract the gels (Fig. 4 b3), probably be-
cause the cells did not surmount the tension present in
the matrix.
Thus, matrix contraction depends on the presence of fi-
broblasts [7, 15, 45, 46], the use of serum [7, 44, 46], and
the glycation cross-linking [17]. Additionally, the degree of
contraction also depends on the initial collagen concentra-
tion [15], the number of cell passages [7, 15, 46] and the
temperature [46].
Even though, we have not performed stiffness experi-
ments when cells are seeded into the matrices, our results
suggests that the effect of the matrix on the cells could be
because of the matrix biomechanics’ microenvironment,
the ECM protein cross-links or even either microenviron-
ment factors that can be produced under these conditions.
In support of this interpretation, other authors have re-
ported that an increase in the ECM protein concentration,
as well as the matrix cross-linking and the mechanical in-
teractions between the ECM and the cells, promote cell
proliferation, the acquisition of a contractile phenotype and
the modulation of gel contractility, which they attribute to
the matrix stiffness [4–8, 15, 17, 38, 40, 42, 43].
Conclusions
Human lung fibroblasts are able to grow into 3D collage-
nated and stiffened matrices under specific conditions.
The increase of ECM cross-linking via non-enzymatic gly-
cation at low ribose concentrations and the biomechanical
interactions between the ECM and the cells embedded in
it induces fibroblast phenotype and metabolic changes.
Altogether could modulate the gels’ contractility. This ap-
plicable model with a mechanic and oxidative modified
environment could resemble an aging/fibrotic ECM.Accordingly, such model may be useful for investigating
cell behavior and phenotypic changes that occur during
the processes of lung fibrosis and aging, as well as for test-
ing different antifibrotic therapies in vitro.
Table 1. Summary results from the post-glycated three-
dimensional collagen matrices. PBS: phosphate-buffered sa-
line; DMEM: Dulbecco’s modified Eagle medium; ex/em:
excitation/emission; nm: nanometers; KPa: KiloPascals; SD:
Standard deviation; mM: miliMolar; N/A: Not Avail-
able; [Ribose]: concentration of ribose; ↓: decreased; ↑:
elevated; ≤: minor or equal; (*) p < 0,05.Additional files
Additional file 1: Markers of primary human normal lung fibroblast.
The primary human normal lung fibroblasts used in this study at passage 3
were analyzed by western blot. a. Tenascin-C (+), E-Cadherin (−), Vimentin
(+++) and β-actin (+++). b. α-tubulin (++) and α-SMA (+).
Additional file 2: Movie of fibroblasts distribution when cultured
into a 3D collagen matrix. Green cells are live cells. Red cells are dead
cells.
Additional file 3: Fibroblasts morphology in collagen 3D matrices.
Different fibroblast morphology was appreciated into 3D collagen
matrices depending on the media conditions (DMEM vs PBS). While with
DMEM the fibroblasts were as long dendritic cells and spindle; in PBS, the
cells appear round, stellar, and as short dendritic cells.
Additional file 4: Fluorescence in cell-free glycated matrices.
Fluorescence intensity increased with higher ribose concentrations
under all conditions (a, b and c) and was independent of the
presence of serum (b and c).Abbreviations
3D: Three-dimensional; AFM: Atomic force microscopy; AGEs: Advanced
glycation end products; BSA: Bovine serum albumin; CRM: Confocal
Reflection Microscopy; DMEM: Dulbecco’s modified Eagle medium;
DNA: Deoxyribonucleic acid; E: Young’s modulus; ECM: Extracellular matrix;
FBS: Fetal bovine serum; IPF: Idiopathic Pulmonary Fibrosis; mM: mili-Molar;
PBS: Phosphate-buffered saline; qPCR: Real-time quantitative reverse
transcription-polymerase chain reaction; RIPA: Radioimmunoprecipitation
assay buffer; RNA: Ribonucleic acid; TNC: Tenascin-C; α-SMA: Alpha-smooth
muscle actin.
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